Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Antiviral Options against SARS-CoV-2 Infection
Aleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, et al.
Viruses (2020) Vol. 12, Iss. 6, pp. 642-642
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Cell Reports (2021) Vol. 35, Iss. 1, pp. 108959-108959
Open Access | Times Cited: 225
Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?
Sangiliyandi Gurunathan, Muhammad Qasim, Youngsok Choi, et al.
Nanomaterials (2020) Vol. 10, Iss. 9, pp. 1645-1645
Open Access | Times Cited: 203
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
Hirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
iScience (2021) Vol. 24, Iss. 4, pp. 102367-102367
Open Access | Times Cited: 163
A novel cell culture system modeling the SARS-CoV-2 life cycle
Xiaohui Ju, Yunkai Zhu, Yuyan Wang, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 3, pp. e1009439-e1009439
Open Access | Times Cited: 141
Therapeutic potential of pyrrole and pyrrolidine analogs: an update
N. Jeelan Basha, S. M. Basavarajaiah, K. Shyamsunder
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2915-2937
Open Access | Times Cited: 115
Homoharringtonine: mechanisms, clinical applications and research progress
Wen Wang, Lan He, Ting Lin, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
The acid sphingomyelinase/ceramide system in COVID-19
Johannes Kornhuber, Nicolas Hoertel, Erich Gulbins
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 307-314
Open Access | Times Cited: 95
Tomato (Solanum lycopersicum L.) seed: A review on bioactives and biomedical activities
Manoj Kumar, Maharishi Tomar, Deep Jyoti Bhuyan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112018-112018
Open Access | Times Cited: 89
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z. Chen, Paul Shinn, Zina Itkin, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 87
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 11, pp. 2339-2350
Open Access | Times Cited: 86
Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 74
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 282-282
Open Access | Times Cited: 70
UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses
Sanjeev K. Bhardwaj, Harpreet Singh, Akash Deep, et al.
The Science of The Total Environment (2021) Vol. 792, pp. 148548-148548
Open Access | Times Cited: 65
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review
Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3006-3016
Open Access | Times Cited: 62
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Pengxuan Ren, Weijuan Shang, Wanchao Yin, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 2, pp. 483-493
Open Access | Times Cited: 60
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 57
Antibacterial and antiviral chitosan oligosaccharide modified cellulosic fibers with durability against washing and long-acting activity
Jinxin Lan, Jiazhen Chen, Ruiqi Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 231, pp. 123587-123587
Open Access | Times Cited: 28
Identification and Tracking of Antiviral Drug Combinations
Aleksandr Ianevski, Rouan Yao, Svetlana Biza, et al.
Viruses (2020) Vol. 12, Iss. 10, pp. 1178-1178
Open Access | Times Cited: 65
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials
Rohan Chakraborty, Suhel Parvez
Biochemical Pharmacology (2020) Vol. 180, pp. 114184-114184
Open Access | Times Cited: 64
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
Jordi Rodon, Jordana Muñoz‐Basagoiti, Daniel Pérez-Zsolt, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 51
Advances in Neutralization Assays for SARS‐CoV‐2
Yuying Lu, Wang Jin, Qianlin Li, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 3
Open Access | Times Cited: 51
Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 46
Mono- and combinational drug therapies for global viral pandemic preparedness
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104112-104112
Open Access | Times Cited: 30
Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury
Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 43
Endoplasmic reticulum stress and NF‐kB activation in SARS‐CoV‐2 infected cells and their response to antiviral therapy
Desirée Bartolini, Anna Maria Stabile, Carmine Vacca, et al.
IUBMB Life (2021) Vol. 74, Iss. 1, pp. 93-100
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top